DavidFriedmanGottliebMD

Hematology • Baltimore, MD

Physician

Join to view full profile

Dr. Gottlieb is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gottlieb's full profile

Already have an account?

Office
Greater Baltimore Medical Center
6701 N Charles St, Suite 201
Baltimore, MD 21204

Education & Training

University of MarylandFellowship, Hematology and Medical Oncology, 2019 - 2022
University of MarylandResidency, Internal Medicine, 2017 - 2019
Albany Medical CollegeClass of 2016

Certifications & Licensure

MD State Medical License 2022 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Publications & Presentations

PubMed

5 citations
Low utility of the H-Score and HLH-2004 criteria to identify patients with secondary hemophagocytic lymphohistiocytosis after CAR-T cell therapy for relapsed/refractor...
Dong Won Kim, Ali Bukhari, Forat Lutfi, Facundo Zafforoni, Fikru Merechi
Leukemia & Lymphoma. 2022-06-01
14 citations
Chimeric antigen receptor T-cell therapy after allogeneic stem cell transplant for relapsed/refractory large B-cell lymphoma.
Forat Lutfi, Noa G. Holtzman, Jonathan Siglin, Ali Bukhari, Moaath Mustafa Ali
British Journal of Haematology. 2021-01-01
14 citations
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma.
Forat Lutfi, Noa G. Holtzman, Ankit Kansagra, Moaath K. Mustafa Ali, Ali Bukhari
British Journal of Haematology. 2021-09-09

Press Mentions

What to Know About Living with Multiple Myeloma at a Young AgeJanuary 17th, 2024